Archives of story1 - Page 3 of 4 - Affluent Medical

2018

Given their joint undertakings and the synergies that could potentially be generated, grouping of Epygon, Kardiozis, Kephalios and MyoPowers, to create Affluent Medical.   Formation of the Company and operation of contributions in kind of all the shares and...

2017

Entering into joint venture contracts between Shanghai Zuquan Investment Management Company Limited on one side and Epygon, Kephalios and MyoPowers on the other side.

2016

Bpifrance assistance granted to MyoPowers for the “Artus” program.

2015

Capital increase for MyoPowers for an amount of €4,500,000 subscribed mainly by funds generated by Truffle Capital and Novartis Bioventures Limited.   Entering into consortium agreement relating to the “Mivana” project “Innovative medical devices and techniques...

2014

Creation of MyoPowers, company specialized in the development of artificial muscles for the treatment of severe incontinence. Capital increase for Epygon for an amount of €1,240,000 subscribed mainly by funds generated by Truffle Capital. Kalios™ and Epygon enter into...